Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy Participants

NCT07752069 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Lipoprotein Disorder

Interventions

DRUG: HRS-5346
DRUG: HRS-5346

Sponsor

Shandong Suncadia Medicine Co., Ltd.